US Patent Family Members and Approved Drugs for Japan Patent: 6050226
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: JP6050226
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Get Started Free | 2031-05-26 | bevacizumab | Genentech, Inc. | AVASTIN |
| ⤷ Get Started Free | 2031-08-18 | bevacizumab | Genentech, Inc. | AVASTIN |
| ⤷ Get Started Free | 2032-01-14 | bevacizumab | Genentech, Inc. | AVASTIN |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
